Announcements Call for Application for HEaL Institute’s Short-Duration Intensive Training Program of in Public Health Ethics to be held at Tata Institute of Social Sciences during April 14-17, 2020   |   Call for applications by The Migration Health South Asia Network for skill & capacity development training workshop to be held in 6-9 April 2020   |   Open Letter: Stop the war on Syria’s hospitals

New regulations on compensation for injury and death in drug trials

Amar Jesani

DOI: 10.20529/IJME.2013.026


In 2005, the government amended Schedule Y of the Drugs and Cosmetics Act, 1940, and Rules, 1945, to liberalise the conduct of global drug trials in India. Proponents of this policy had asserted that we needed less, and not more, regulation, in order to expand the business of drug trials. Many from the medical profession, the bioethics community and civil society groups have been critical of this policy.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US